DEUTSCHE BANK AG\
BankPosition in PTGX — Protagonist Therapeutics, Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in PTGX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,386,500
+$4,163,966 QoQ
Shares Held
141,838
+13.1% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#57
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. PTGX ranks #25 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,386,500 | 141,838 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $13,222,534 | 125,451 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $9,210,875 | 105,460 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,786,391 | 117,212 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,144,033 | 111,164 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,177,008 | 65,695 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $5,324,173 | 137,932 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $5,407,605 | 120,169 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $31,474,258 | 908,348 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $26,349,617 | 910,806 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $20,866,573 | 910,012 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,199,508 | 71,913 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $23,789,767 | 861,324 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,054,493 | 958,891 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,098,972 | 925,662 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,848,152 | 812,355 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,469,050 | 817,832 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $19,472,606 | 822,323 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,210,621 | 824,872 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $14,588,696 | 823,290 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $36,878,882 | 821,722 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $662,029 | 25,561 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $507,264 | 25,162 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $320,091 | 16,373 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $204,114 | 11,558 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $43,192 | 6,118 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||